- London mayor flies Palestinian flag at town hall to support Gaza
- U.N. condemns Israel, U.S. for not sharing Iron Dome with Hamas
- Eric Cantor says he’ll resign on Aug. 18
- Ted Nugent slams ‘lying freaks’ at liberal media: I’m ‘doing God’s work’
- Joe Biden’s secret love: Skinny-dipping, Secret Service agents say
- Just-forged Israel-Hamas cease-fire ends in rocket fire
- Obama military downsizing leaves U.S. too weak to counter global threats, panel finds
- Sen. Tom Coburn vows to slow down budget-busting bills ahead of recess
- Obama fantasizes about more executive power, signs new order on federal contractors
- Clintons call Klein, Halper, Kessler ‘a Hat Trick of despicable actors’: report
New gonorrhea guidelines call for shots, not pills, to fight superstrain
Question of the Day
Americans who test positive for gonorrhea should now be treated with a shot, not just pills, the federal government said Thursday in a significant rewrite of the recommended treatment for the long-dreaded sexually transmitted disease.
The shift is prompted by evidence that the gonorrhea bacterium is rapidly building resistance to cefixime, an anti-gonorrhea oral antibiotic that was once highly effective against the disease, the Centers for Disease Control and Prevention (CDC) said.
Now instead of taking cefixime pills, patients should receive a shot of ceftriaxone, which is still effective against gonorrhea, plus a round of general antibiotics, either azithromycin or doxycycline.
“This change is a critical pre-emptive strike to preserve ceftriaxone, our last proven treatment option” against gonorrhea, said Dr. Kevin Fenton, director of the National Center for HIV/AIDs, Viral Hepatitis, Sexually Transmitted Disease (STD) and Tuberculosis Prevention at the CDC.
Gonorrhea, which has plagued mankind since biblical days, first became curable with the introduction of sulfa drugs in the 1940s.
However, the bacterium, Neisseria gonorrhoeae, is a master of mutation, and over the decades, it has learned how to survive several classes of drugs, including penicillins, tetracyclines and fluoroquinolones.
In the last five years, the mutated disease has proven too powerful for drugs in the cephalosporins class; with Thursday’s announcement, only the ceftriaxone shot is considered a front-line defense.
The change means that new anti-gonorrhea medicines must be found quickly, and budgets and staff of state STD health agencies must be replenished, said William Smith, executive director of the National Coalition of STD Directors (NCSD).
Treatment of gonorrhea has now shifted from a simple act of taking pills to getting an injection by a certified health professional, said Mr. Smith. In addition to meeting this new need, NCSD health departments, which have “bare bones” budgets, will also be expected to ensure that gonorrhea patients are fully cured, as well as find, test, treat and re-test a patient’s sex partners of the previous 60 days.
“In the face of this real and emerging threat, federal, state and local governments must reinvest in health department STD programs without delay,” said Mr. Smith.
CDC officials said Thursday that no cases of “treatment failure” have been found in the U.S., but several cases have been reported in Asia and Europe. One gonorrhea “superbug,” dubbed H041, which didn’t respond to known antibiotics, was found in the throat of a sex worker in Japan.
According to a CDC computer model, if antibiotic-resistant gonorrhea cases continue to rise in the United States without additional remedies, the nation could expect to see its gonorrhea caseload leap from the current 600,000 to 5.9 million in seven years.
The new gonorrhea guidelines were published in the new Morbidity and Mortality Weekly Report.
With an estimated 600,000 new cases each year, gonorrhea is the second most commonly reported STD in the United States. Only about half of infections are reported because gonorrhea is often asymptomatic, especially in women, and particularly when the infection is in the throat or rectum.
© Copyright 2014 The Washington Times, LLC. Click here for reprint permission.
About the Author
Cheryl Wetzstein covers family and social issues as a national reporter for The Washington Times. She has been a reporter for three decades, working in New York City and Washington, D.C. Since joining The Washington Times in 1985, she has been a features writer, environmental and consumer affairs reporter, and assistant business editor.
Beginning in 1994, Mrs. Wetzstein worked exclusively ...
- Massachusetts lawmakers OK new abortion clinic buffer law
- Mississippi abortion law can't be enforced
- Federal appeals court rules against Virginia's gay marriage ban
- Events honoring 20th National Parents' Day reaffirm family
- '50 Shades' movie trailer outrages anti-porn groups
Latest Blog Entries
- Gay therapy ban author seeks Calif. House seat
- Transgender 'bathroom law' gets 5,000 more signatures
- Pro-life, stem-cell bill signed into law by Kansas Gov. Sam Brownback
- N. Dakota lawmakers approve tough abortion bill
- Pope Benedict XVI's successor should allow priests to get a new title: Husband, poll finds
TWT Video Picks
Both parties recognize the Democrats' scam
- Inside the Ring: Israel surprised by Hamas tunnel network
- Obama military strategy too weak for future security, panel reports
- Israel surprised by Hamas tunnel network
- PRUDEN: Cooling the manufactured impeachment panic
- Chicken pox outbreak puts illegal immigrant facility on lockdown
- 'Big Bang' star Mayim Bialik helps send bulletproof vests to IDF
- Congress leaves Obama holding the burden of border children
- Just-forged Israel-Hamas 3-day cease-fire ends in rocket fire
- Islamic militants seize Benghazi as U.S. evacuates Libya
- 3 African leaders cancel trip to U.S. over Ebola outbreak; Obama still plans summit
Obama's biggest White House 'fails'
Celebrities turned politicians
Athletes turned actors
20 gadgets that changed the world